Regenxbio Inc (RGNX)
9.15
-0.05
(-0.54%)
USD |
NASDAQ |
Apr 25, 16:00
9.155
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Shareholders Equity (Quarterly): 259.65M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 1.528B |
| AbbVie Inc | 3.325B |
| Regeneron Pharmaceuticals Inc | 29.35B |
| Vertex Pharmaceuticals Inc | 16.41B |
| PTC Therapeutics Inc | -1.098B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.99M |
| Total Liabilities (Quarterly) | 206.34M |
| Current Ratio | 2.694 |